Alcohol and hepatitis C

Seminars in Liver Disease

Volumn 24, Issue 3, 2004, Pages 305-315

  Safdar, Kamran ^a   Schiff, Eugene R ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

Alcohol; Cirrhosis; Hepatitis C virus; Hepatocellular carcinoma; Interferon

Indexed keywords

ALCOHOL; INTERFERON;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; APOPTOSIS; COMORBIDITY; HEPATITIS C; HEPATITIS C VIRUS; HOST SUSCEPTIBILITY; HUMAN; LIVER CELL CARCINOMA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STEATOSIS; SYSTEMATIC REVIEW;

ALCOHOLISM; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; HEPATITIS; HUMANS; INTERFERON-ALPHA; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS;

EID: 4444291706     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-832942     Document Type: Review

References (175)

1. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002;36(Suppl 5):S35-S46
2. Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-1466
3. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis c virus. Hepatology 1990;12:671-675
4. National Institute of Health Management of hepatitis C: 2002. National Institute of Health Consensus Development Conference Statement. Available at: hhtp://consensus.nih. gov/cons/116/Hepc091202.pdf, Accessed September 28, 2002
5. Poynard T, Marcellin P, Lee SS, et al. Randomised trial of interferon alpha 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis c virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 1998;352:1426-1432
6. Romeo R, Colombo M, Rumi M, et al. Lack of association between type of hepatitis c virus, serum load and severity of liver disease. J Viral Hepat 1996;3:183-190
7. Powell EE, Edwards-Smith CJ, Hay JL, et al. Host genetic factors influence progression in chronic hepatitis C. Hepatology 2000;31:828-833
8. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, DOSVIRC Groups. Lancet 1997;349:825-832
9. Roudot-Thoraval F, Bastie A, Pawlotsky JM, Dhumeaux D. Epidemiological factors affecting the severity of hepatitis c virus related liver disease. A French survey of 6664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology 1997;26:485-490
10. Ostapowicz G, Watson KJR, Ocarnini SA, et al. Role of alcohol in the progression of liver disease caused by hepatitis virus infection. Hepatology 1998;27:1730-1735
11. Koff RS, Dienstag JL. Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 1995;15:101-109
12. Befrits R, Hedman M, Blomquist L, et al. Chronic hepatitis C in alcoholic patients: prevalence, genotypes and correlation to liver disease. Scand J Gastroenterol 1995;30:1113-1118
13. Mendenhall CL, Moritz T, Rouster S, et al. Epidemiology of hepatitis C among veterans with alcoholic liver disease. Am J Gastroenterol 1993;88:1022-1026
14. Coelho-Little ME, Jeffers LJ, Bernstein DE, et al. Hepatitis C virus in alcohol patients with and without clinically apparent liver disease. Alcohol Clin Exp Res 1995;19:1173-1176
15. Caldwell SH, Li X, Rourk RM, et al. Hepatitis C infection by polymerase chain reaction in alcoholics: false positive ELISA results and the influence of infection on a clinical prognostic score. Am J Gastroenterol 1993;88:1016-1021
16. Nalpas B, Thiers V, Pol S, et al. HCV infection in alcoholics. Gastroenterology 1993;28(Suppl 5):88-90
17. Zarski JP, Thelu MA, Moulin C, et al. Interest of the detection of hepatitis c Virus RNA in patients with alcoholic liver disease. Comparison with the HBV status. J Hepatol 1993;17:10-14
18. Oshita M, Hyashi N, Kasahara A, et al. Increased serum hepatitis c virus RNA Among alcoholic patients with chronic hepatitis C. Hepatology 1994;20:1115-1120
19. Sata M, Fukuizumi K, Uchimura Y, et al. Hepatitis C virus infection in patients With clinically diagnosed alcoholic liver diseases. J Viral Hepat 1996;3:143-148
20. Nishiguchi S, Kuroki T, Yabusako T, et al. Detection of hepatitis c virus Antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology 1991;14: 985-989
21. Jiang JJ, Dubois F, Driss F, et al. Clinical impact of drug addiction in alcoholics. Alcohol Alcohol 1995;30:55-60
22. Nalpas B, Thiers V, Pol S, et al. Hepatitis C viremia and anti-HCV antibodies in alcoholics. J Hepatol 1992;14:381-384
23. Verbaan H, Andersson K, Eriksson S. Intravenous drug abuse - the major route of hepatitis C virus transmission among alcohol dependent individuals? Scand J Gastroenterol 1993;28:714-718
24. Brillanti S, Masci C, Siringo S, et al. Serological and histological aspects of hepatitis C virus infection in alcoholic patients. J Hepatol 1991;13:347-350
25. Caldwell SH, Jeffers LJ, Ditomaso A, et al. Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors. Am J Gastroenterol 1991;86:1219-1223
26. Centers for Disease Control Hepatitis C. Epidemiology. Available at: http://CDCGov/ncidod/diseases/hepatitisc/ training (CDC website)
27. Howell C, Jeffers LJ, Hoofnagle JH. Hepatitis C in African Americans: summary of a workshop. Gastroenterology 2000; 119:1385-1396
28. Pares A, Caballeria J, Bruguera M, Torres M, Rodes J. Histological course of Alcoholic hepatitis: influence of abstinence, sex and extent of hepatic damage. J Hepatol 1986;2:33-42
29. Becker U, Deis A, Sorensen RT, et al. Prediction of risk of liver disease by alcohol intake, sex and age: a prospective population study. Hepatology 1996;26:1025-1028
30. Bellentani S, Pozzato G, Saccoccio G, et al. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut 1999;44:874-880
31. Bellentani S, Saccoccio G, Costa G, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997;41:845-850
32. Seef LB, Buskell-Bales Z, Wright EC, et al. Long term mortality after transfusion associated non-A, non-B hepatitis. N Engl J Med 1992;327:1906-1911
33. Serfaty L, Chazouilleres O, Poujo-Rober A, et al. Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case control study. Hepatology 1997; 26:776-779
34. Wiley TE, McCarthy M, Breidi L, et al. Impact of alcohol on the histologic and clinical progression of hepatitis C infection. Hepatology 1998;28:805-809
35. Pessione F, Degos F, Marcellin P, et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histologic lesions in chronic hepatitis C. Hepatology 1998;27:1717-1722
36. Corrao G, Arico S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 1998;27:914-919
37. Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral and environmental factors. JAMA 2000;284:450-456
38. Harris DR, Gonin R, Alter HJ, et al. The relationship of acute transfusion associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med 2001;134:120-124
39. Niederau C, Lange S, Heintges T, et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study Hepatology 1998;28:1687-1695
40. Pol S, Fontaine H, Carnot F, et al. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients. J Hepatol 1998;29:12-19
41. Shev S, Dhillon AP, Lindh M, et al. The importance of cofactors in the histologic progression of minimal and mild chronic hepatitis C. Liver 1997;17:215-223
42. Shiomi S, Kuroki T, Minamitani S, et al. Effect of drinking on outcome of cirrhosis in patients with hepatitis B or C. J Gastroenterol Hepatol 1992;7:274-276
43. Sachithanandan S, Kay E, Leader M, et al. The effect of light drinking on HCV liver disease: the jury is still out. Biomed Pharmacother 1997;51:295-297
44. Hezode C, Lonjon I, Roudot-Thoraval F, et al. Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C and specific influence of steatosis: a prospective study. Aliment Pharmacol Ther 2003;17:1031-1037
45. Westin J, Lagging LM, Spak F, et al. Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepat 2002;9:235-241
46. DiMartino V, Rufat P, Boyer N, et al. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long term retrospective cohort study. Hepatology 2001;34:1193-1199
47. Benhamou Y, Di Martino V, Bochet M, et al. Factors affecting liver fibrosis in human immunodeficiency virus and hepatitis C coinfected patients: impact of protease inhibitor therapy. Hepatology 2001;34:283-287
48. Kondili LA, Tosti ME, Szklo M, et al. The relationships of chronic hepatitis and cirrhosis to alcohol intake, hepatitis B and C, and delta virus infection: a case control study in Albania. Epidemiol Infect 1998;121:391-395
49. Nevins CL, Malaty H, Velez ME, Anand BS. Interaction of alcohol and hepatitis C virus infection on severity of liver disease. Dig Dis Sci 1999;44:1236-1242
50. Khan KN, Yatsuhashi H. Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients. Alcohol Alcohol 2000;35:286-295
51. Donato F, Tagger A, Gelatti U, et al. Alcohol and hepatocellular carcinoma: the effect of life time intake of and hepatitis virus infections in men and women. Am J Epidemiol 2002;155:323-331
52. Alemy-Carreau M, Durbec JP, Giordanella J, et al. Lack of interaction between hepatitis C virus and alcohol in the pathogenesis of cirrhosis. A statistical study. J Hepatol 1996; 25:627-632
53. Uchimura Y, Sata M, Kage M, et al. A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver 1995;15:300-306
54. Cook RT. Alcohol abuse, alcoholism and damage to the immune system - a review. Alcohol Clin Exp Res 1998;22: 1927-1942
55. Jerrells TR, Pruett SB. Immunotoxic effects of ethanol. In Dean JH, Luster MI, Munson AE, Kimber I, eds. Immunotoxicology and Immunopharmacology. New York: Raven Press; 1994:323-347
56. Mufti SI, Prabhala R, Moriguchi S, et al. Functional and numerical alterations induced by ethanol in the cellular immune system. Immunopharmacology 1988;15:85-94
57. Bounds W, Betzing KW, Stewart RM, et al. Social drinking and the immune response: impairment of lymphokine activated killer activity. Am J Med Sci 1994;307:391-395
58. Chiappelli F, Kung M, Lee P, et al. Alcohol modulation of human normal T cell activation, maturation and migration. Alcohol Clin Exp Res 1995;19:539-544
59. Taieb J, Mathurin P, Poynard T, et al. Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease. Lancet 1998; 351:1930-1931
60. Szabo G, Mandrekar P, Dolganiuc A, et al. Reduced alloreactive T cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13 and decreased IFN gamma levels. Alcohol Clin Exp Res 2001;25:1766-1772
61. Tsai SL, Liaw YF, Chen MH, et al. Detection of type 2 like T helper cells in hepatitis C virus infection: implications for hepatitis C chronicity. Hepatology 1997;25:449-458
62. Geissler M, Gesien A, Wands JR. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine expressing plasmids. J Immunol 1997;159:5107-5113
63. Cook RT. Cytoplasmic cytokines in the T cells of chronic alcoholics (letter). Alcohol Clin Exp Res 2000;24:241-243
64. Song K, Coleman RA, Albert C, et al. Th1 cytokine response of CD57+ T cell subsets in healthy controls and patients with alcoholic liver disease. Alcohol 2001;24:155-167
65. Saad AJ, Domiati-Saad R, Jerrells TR. Ethanol ingestion increases susceptibility of mice to Listeria monocytogenes. Alcohol Clin Exp Res 1993;17:75-85
66. Sibley D, Jerrells TR. Alcohol consumption by C57BL/6 mice is associated with depletion of lymphoid cells from the gut associated lymphoid tissues and altered resistance to oral infections with Salmonella typhimurium. J Infect Dis 2000; 182:482-489
67. Slukvin I, Boor PJ, Jerrells TR. Inhibition of alcoholic fatty liver and hepatic inflammation with a specific recall immune response in alcohol consuming C57B1/6 mice. Clin Exp Immunol 2001;125:123-133
68. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997;99:1472-1477
69. Chang KM, Thimme R, Melpolder JJ, et al. Differential CD4+ and CD8+ T cell responsiveness in hepatitis c virus infection. Hepatology 2001;33:267-276
70. Gruener NH, Lechner F, Jung MC, et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 2001;75:5550-5558
71. Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001;19:65-91
72. Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999;30:595-601
73. Chang KM, Rehermann B, Chisari FV. Immunopathology of hepatitis C. Springer Semin Immunopathol 1997;19: 57-68
74. Pianko S, Patella S, Ostapowicz G, et al. Fas mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection. J Viral Hepat 2001;8:406-413
75. Jerrells TR. Role of activated CD8+ T cells in the initiation and continuation of hepatic damage. Alcohol 2002;27: 47-52
76. Balkow S, Kersten A, Tran TT, et al. Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection. J Virol 2001;75:8781-8791
77. Jerrells TR, Mitchell K, Pavlik J, et al. Influence of ethanol consumption on experimental viral hepatitis. Alcohol Clin Exp Res 2002;26:1734-1746
78. Farinati F, Cardin R, De Maria N, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 1995;22:449-456
79. De Maria N, Coloantoni A, Fagiuoli S, et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 1996;21:291-295
80. Romero MJ, Bosch-Morell F, Romero B, et al. Serum malondialdehyde: possible use for the clinical managements of chronic hepatitis C patients. Free Radic Biol Med 1998; 25:993-997
81. Barbaro G, Di Lorenzo G, Ribersani M, et al. Serum and hepatic glutathione concentrations in chronic hepatitis C patients related to hepatitis C virus genotype. J Hepatol 1999;30:774-782
82. Kageyama F, Kobayashi Y, Kawasaki T, et al. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C. Am J Gastroenterol 2000;95:1041-1050
83. Jain SK, Pemberton PW, Smith A, et al. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol 2002;36:805-811
84. Albano E. Free radicals and alcohol induced liver injury. In: Sherman CDIN, Preedy VR, Watson RR eds. Ethanol and the Liver. London: Taylor and Francis; 2002:153-190
85. Clot P, Tabone M, Arico S, et al. Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake. Gut 1994;35:1637-1643
86. Aleynik SI, Leo MA, Aleynik MK, Lieber CS. Increased circulating products of lipid peroxidation in patients with alcoholic liver disease. Alcohol Clin Exp Res 1998;22:192-196
87. Meager EA, Barry, OP, Burke A, et al. Alcohol induced generation of lipid peroxidation products in humans. J Clin Invest 1999;104:805-813
88. Nimela O, Parkkila S, Britton RS, et al. Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver disease. J Lab Clin Med 1999;133:451-460
89. Hoek JB, Cahill A, Pastorino JG. Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology 2002;122: 2049-2063
90. Letteron P, Fromenty B, Terris B, et al. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol 1996;24:200-208
91. Letteron P, Duchatelle V, Berson A, et al. Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol abusers. Gut 1993;34:409-414
92. Perlemuter G, Sabile A, Letteron P, et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral related steatosis. FASEB J 2002;16:185-194
93. Okuda M, Li K, Beard MR, et al. Mitochondrial injury, oxidative stress and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002; 122:366-375
94. Moriya K, Nakagawa K, Santa T, et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus associated hepatocarcinogenesis. Cancer Res 2001; 61:4365-4370
95. Rigamonti C, Mottaran E, Reale E, et al. Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C. Hepatology 2003;38:42-49
96. Perlemuter G, Letteron P, Carnot F, et al. Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model. J Hepatol 2003;39:1020-1027
97. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 1996;313:17-29
98. Girotti AW. Lipid hydroperoxide generation, turnover and effector action in biological systems. J Lipid Res 1998;39: 1529-1542
99. Schmid RM, Adler G. NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases. Gastroenterology 2000; 118:1208-1228
100. Baeuerle PA. Proinflammatory signaling: last pieces in the NF-kappaB puzzle? Curr Biol 1998;8:R19-R22
101. Cressman DE, Greenbaum LE, Haber BA, et al. Rapid activation of post hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver. J Biol Chem 1994;269:30429-30435
102. Tai DI, Tsai SL, Chen YM, et al. Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 2000; 31:656-664
103. Kim WH, Hong F, Jaruga B, et al. Additive activation of hepatic NF-kappa B by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF-alpha receptor 1-independent and -dependent mechanisms. FASEB J 2001;15:2551-2553
104. Gao B. Integration of alcohol and hepatitis viral proteins: implication in synergistic effect of alcohol drinking and viral hepatitis on liver injury. Alcohol 2002;26:69-72
105. Schiff ER. Hepatitis C and alcohol. Hepatology 1997; 26(Suppl 1):39S-42S
106. Mendenhaall CL, Seef L, Diehl AM, et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence. Hepatology 1991;14:581-589
107. Pares A, Barrera JM, Caballeria J, et al. Hepatitis virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 1990;12:1295-1299
108. Fong TL, Kanel GC, Conrad A, et al. Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology 1994;19:554-557
109. Rosman AS, Paronetto F, Galvin K, et al. Hepatitis C virus antibody in alcoholic patients. Association with the presence of portal and/or lobular hepatitis. Arch Intern Med 1993; 153:965-969
110. Loguercio C, Di Pierro M, Di Marino MP, et al. Drinking habits of subjects with hepatitis C virus related chronic liver disease: prevalence and effect on dinical, virological and pathological aspects. Alcohol Alcohol 2000;35:296-301
111. Cromie SL, Jenkins PJ, Bowden DS, et al. Chronic hepatitis C: effect of alcohol on hepatic activity and viral titer. J Hepatol 1996;25:821-826
112. Anand BS, Velez M. Influence of chronic alcohol abuse on hepatitis C virus replication. Dig Dis 2000;18:168-171
113. Fanning L, Kenny E, Sheehan M, et al. Viral load and clinicopathologic features of chronic hepatitis C in a homogenous patient population. Hepatology 1999;29:904-907
114. Lau YJ, Davis GL, Kniffen J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341:1501-1504
115. Martniot-Peignoux M, Marcellin P, Gournay J, et al. Detection and quantitation of serum HCV RNA by branched DNA amplification in anti-HCV positive blood donors. J Hepatol 1994;20:676-678
116. Romero-Gomez M, Grande L, Nogales MC, et al. Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption. Dig Liver Dis 2001;33: 698-702
117. Haydon GH, Jarvis LM, Blair CS, et al. Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut 1998;42:570-575
118. Sawada M, Takada A, Takase S, et al. Effects of alcohol on the replication of hepatitis C virus. Alcohol Alcohol 1993;28: 85-90
119. Zhang T, Li Y, Lai JP, et al. Alcohol potentiates hepatitis C virus replicon expression. Hepatology 2003;38:57-65
120. Sherman KE, Rouster SD, Mendenhall C, et al. Hepatitis C RNA quasispecies complexity in patients with alcoholic liver disease. Hepatology 1999;30:265-270
121. Takahashi K, Takahashi T, Takahashi S, et al. Difference in quasispecies of the hypervariable region 1 of hepatitis C virus between alcoholic and non alcoholic patients. J Gastroenterol Hepatol 2001;16:416-423
122. Izumi N, Enomoto N, Uchihara M, et al. Hepatic iron contents and response to interferon alpha in patients with chronic hepatitis C. Dig Dis Sci 1996;41:989-994
123. Piperno A, Vergani A, Malosio I, et al. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations. Hepatology 1998;28:1105-1109
124. Smith BC, Gorve J, Guzail MA, et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 1998;27:1695-1699
125. Patel T, Roberts LR, Jones BA, et al. Dysregulation of apoptosis as a mechanism of liver disease: an overview. Semin Liver Dis 1998;18:105-114
126. Pianko S, Patella S, Sievert W. Alcohol consumption induces hepatocyte apoptosis in patients with chronic hepatitis C infection. J Gastroenterol Hepatol 2000;15:798-805
127. Zhu N, Khoshan A, Schneider R, et al. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF induced apoptosis. J Virol 1998;72:3691-3697
128. Scheuer PJ, Ashrafzadeh P, Sherlock S, et al. The pathology of hepatitis C. Hepatology 1992;15:567-571
129. Lefkowitch JH, Schiff ER, Davis GL, et al. Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B. Gastroenterology 1993;104: 595-603
130. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis. Hepatology 1992;15:572-577
131. Czaja AJ, Carpenter HA, Santrach PJ, et al. Host and disease specific factors affecting steatosis in chronic hepatitis C. J Hepatol 1998;29:198-206
132. Hourigan LF, Macdonald GA, Purdie D, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999;29:1215-1219
133. Fiore G, Fera G, Napoli N, et al. Liver steatosis and chronic hepatitis C: a spurious association? Eur J Gastroenterol Hepatol 1996;8:125-129
134. Poupon R, Serfaty S, Amorim M, et al. Combination of steatosis and alcohol intake is the main determinant of fibrosis progression in patients with hepatitis C. Hepatology 1999;30(suppl):406A
135. Adinolfi LE, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001;33:1358-1364
136. Serfaty L, Poujol-Robert A, Carbonell N, et al. Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C. Am J Gastroenterol 2002;97:1807-1812
137. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001;32:492-497
138. Romeo R, Rumi MG, Donato MF, et al. Hepatitis C is more severe in drug users with human immunodeficiency virus infection. J Viral Hepat 2000;7:297-301
139. Harris HE, Ramsay ME, Andrews N, Eldridge KP. Clinical course of hepatitis C virus during the first decade of infection: cohort study. BMJ 2002;324:450-453
140. Kim WR, Gross JB Jr, Poterucha JJ, et al. Outcome of hospital care of liver disease associated with hepatitis C in the United States. Hepatology 2001;33:201-206
141. Bruix J, Barrera JM, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;2:1004-1006
142. Nalpas B, Feitesol M, Brechot C, et al. Alcohol, hepatotropic viruses and hepatocellular carcinoma. Alcohol Clin Exp Res 1995;19:1089-1095
143. Miyakawa H, Sato C, Izumi N, et al. Hepatitis C virus infection in alcoholic liver cirrhosis in Japan: Its contribution to the development of hepatocellular carcinoma. Alcohol Alcohol 1993;1A(Suppl):85-90
144. Takase S, Tsutsumi M, Kawahara H, et al. The alcohol altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease. Hepatology 1993;17:9-13
145. Yamauchi M, Nakahara M, Maezawa Y, et al. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol 1993; 88:39-43
146. Donato F, Tagger A, Chiesa R, et al. Hepatitis B and C virus infection, alcohol drinking and hepatocellular carcinoma: a case control study in Italy. Brescia HCC study. Hepatology 1997;26:579-584
147. Chiba T, Matsuzaki Y, Abei M, et al. Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis. J Gastroenterol 1996;31: 552-558
148. Simonetti RG, Camma C, Fiorello F, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case control study. Ann Intern Med 1992;116:97-102
149. Miyakawa H, Izumi N, Marumo F, Sato C. Roles of alcohol, hepatitis virus infection and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis. Alcohol Clin Exp Res 1996;20(Suppl 1):91A-94A
150. Ikeda K, Saitoch S, Suzuki Y, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: A prospective observation of 2215 patients. J Hepatol 1998;28:930-938
151. Kuwana K, Ichida T, Kamimura T, et al. Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12: 149-155
152. Aizawa Y, Shibamoto Y, Takagi I. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. Cancer 2000;89:53-59
153. Matsuda Y, Amuro Y, Higashino K, et al. Relation between markers for viral hepatitis and clinical features of Japanese patients with hepatocellular carcinoma: possible role of alcohol in promoting carcinogenesis. Hepatogastroenterology 1995;42:151-154
154. Noda K, Yoshira H, Suzuki K, et al. Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma: its relationship to alcoholic drinking and the age of transfusion. Alcohol Clin Exp Res 1996;20:95A-100A
155. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002;36(Suppl 1):S74-S83
156. Hassan MM, Hwang LU, Hatten CJ, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002;36:1206-1213
157. Shimauchi Y, Tanaka M, Koga K, et al. Clinical characteristics of patients in their 40s with HCV antibody positive hepatocellular carcinoma. Alcohol Clin Exp Res 2000; 24(Suppl 4):64S-67S
158. Yamanaka T, Shiraki K, Nakazaawa S, et al. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis. Anticancer Res 2001;21:2937-2940
159. Kubo S, Kinoshita H, Hirohashi K, et al. High malignancy of hepatocellular carcinoma in alcoholic patients with hepatitis C virus. Surgery 1997;121:425-429
160. Okada S, Ishii H, Nose H, et al. Effect of heavy alcohol intake on long term results after curative resection of hepatitis C virus related hepatocellular carcinoma. Jpn J Cancer Res 1996;87:867-873
161. Bhattacharya R, Shuhart MC. Hepatitis C and alcohol. Interactions, outcomes and implications. J Clin Gastroenterol 2003;36:242-252
162. Inoue H, Seitz HK. Viruses and alcohol in the pathogenesis of primary hepatic carcinoma. Eur J Cancer Prev 2001;10: 107-110
163. Peters MG, Terrault NA. Alcohol use and hepatitis C. Hepatology 2002;36(Suppl 1):S220-S225
164. Schiff ER. The alcoholic patient with hepatitis C virus infection. Am J Med 1999;107:95S-99S
165. Jamal MM, Morgan TR. Liver disease in alcohol and hepatitis C. Best Pract Res Clin Gastroenterol 2003;17:649-662
166. Okazaki M, Yoshihara H, Suzuki K, et al. Efficacy of interferon therapy inpatients with chronic hepatitis C. Comparison between drinkers and non drinkers. Scand J Gastroenterol 1994;29:1039-1043
167. Ohnishi K, Matsuo S, Matsutani K, et al. Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers. Am J Gastroenterol 1996;91:1374-1379
168. Mochida S, Ohnishi K, Matsuo S, et al. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis. Alcohol Clin Exp Res 1996;20:371A-377A
169. Tabone M, Sidoli L, Laudi C, et al. Alcohol abstinence does not offset the strong negative effect of lifetime alcohol consumption on the outcome of interferon therapy. J Viral Hepat 2002;9:288-294
170. Koizumi K, Enomoto N, Kurosaki M, et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 1995;22:30-35
171. Zylberg H, Fontaine H, Thepot V, et al. Triggering of acute alcoholic hepatitis by alpha interferon therapy. J Hepatol 1999;30:722-725
172. Van Thiel DH, Friedlander L, Fagiuoli S, et al. Response to interferon alpha is influenced by the iron content of the liver. J Hepatol 1994;20:410-415
173. Olynyk JK, Reddy KR, Di Bisceglie AM, et al. Hepatic iron concentration as a predictor of response to interferon alpha therapy in chronic hepatitis C. Gastroenterology 1995;108: 1104-1109
174. Vento S, Cainelli F. Does hepatitis C virus cause severe liver disease only in people who drink alcohol? Lancet Infect Dis 2002;2:303-309
175. Regev A, Jeffers LJ. Hepatitis C and alcohol. Alcohol Clin Exp Res 1999;23:1543-1551